{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:02:26Z","timestamp":1792598546837,"version":"4.5.0"},"reference-count":106,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T00:00:00Z","timestamp":1733356800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82070854"],"award-info":[{"award-number":["82070854"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Diabetes and its Complications"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.jdiacomp.2024.108929","type":"journal-article","created":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T23:08:51Z","timestamp":1733440131000},"page":"108929","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Uric acid in diabetic microvascular complications: Mechanisms and therapy"],"prefix":"10.1016","volume":"39","author":[{"given":"Xin","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Qiu","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdiacomp.2024.108929_bb0005","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ijcard.2015.08.109","article-title":"Regulation of uric acid metabolism and excretion","volume":"213","author":"Maiuolo","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jdiacomp.2024.108929_bb0010","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/sdi.12735","article-title":"The physiology of uric acid and the impact of end-stage kidney disease and dialysis","volume":"32","author":"Murea","year":"2019","journal-title":"Semin Dial"},{"key":"10.1016\/j.jdiacomp.2024.108929_bb0015","doi-asserted-by":"crossref","first-page":"9221","DOI":"10.3390\/ijms22179221","article-title":"Molecular biological and clinical understanding of the pathophysiology and treatments of hyperuricemia and its association with metabolic syndrome, cardiovascular diseases and chronic kidney disease","volume":"22","author":"Yanai","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jdiacomp.2024.108929_bb0020","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.2337\/db21-0099","article-title":"Mineralocorticoid receptor pathway and its antagonism in a model of diabetic retinopathy","volume":"70","author":"Zhao","year":"2021","journal-title":"Diabetes"},{"key":"10.1016\/j.jdiacomp.2024.108929_bb0025","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.jare.2017.03.003","article-title":"Physiological functions and pathogenic potential of uric acid: a review","volume":"8","author":"El Ridi","year":"2017","journal-title":"J Adv Res"},{"key":"10.1016\/j.jdiacomp.2024.108929_bb0030","doi-asserted-by":"crossref","first-page":"3188","DOI":"10.3390\/ijms23063188","article-title":"Uric acid and oxidative stress-relationship with cardiovascular, metabolic, and renal impairment","volume":"23","author":"Gherghina","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jdiacomp.2024.108929_bb0035","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00406-017-0817-7","article-title":"Antioxidant uric acid in treated and untreated subjects with major depressive disorder: a meta-analysis and meta-regression","volume":"268","author":"Bartoli","year":"2018","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"10.1016\/j.jdiacomp.2024.108929_bb0040","doi-asserted-by":"crossref","first-page":"9221","DOI":"10.3390\/ijms22179221","article-title":"Molecular biological and clinical understanding of the pathophysiology and treatments of hyperuricemia and its association with metabolic syndrome, cardiovascular diseases and chronic kidney disease","volume":"22","author":"Hidekatsu","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jdiacomp.2024.108929_bb0045","first-page":"1","article-title":"Japanese Society of Gout and Uric & nucleic acids 2019 guidelines for management of hyperuricemia and gout 3rd edition","volume":"44","author":"Hisatome","year":"2020","journal-title":"Gout and Uric & Nucleic Acids"},{"key":"10.1016\/j.jdiacomp.2024.108929_bb0050","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1093\/ndt\/gfh094","article-title":"Exercise-induced acute renal failure associated with renal hypouricaemia: results of a questionnaire-based survey in Japan","volume":"19","author":"Ohta","year":"2004","journal-title":"Nephrology Dialysis Transplantation"},{"key":"10.1016\/j.jdiacomp.2024.108929_bb0055","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.jare.2016.11.004","article-title":"Uric acid in the pathogenesis of metabolic, renal, and cardiovascular diseases: a review","volume":"8","author":"Usama","year":"2017","journal-title":"J Adv Res"},{"key":"10.1016\/j.jdiacomp.2024.108929_bb0060","doi-asserted-by":"crossref","first-page":"652","DOI":"10.3390\/biomedicines10030652","article-title":"Hypouricemia and Urate Transporters","volume":"10","author":"Naoyuki","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.jdiacomp.2024.108929_bb0065","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1007\/s13760-022-01978-1","article-title":"Serum uric acid and diabetic peripheral neuropathy: a double-edged sword","volume":"123","author":"Zhuang","year":"2023","journal-title":"Acta Neurol Belg"},{"key":"10.1016\/j.jdiacomp.2024.108929_bb0070","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.diabres.2018.02.023","article-title":"IDF diabetes atlas: global estimates of diabetes prevalence for 2017 and projections for 2045","volume":"138","author":"Cho","year":"2018","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.jdiacomp.2024.108929_bb0075","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.2147\/DMSO.S363311","article-title":"Prevalence of hyperuricemia and the relationship between serum uric acid and hypertension in new onset diabetic patients: a cross-sectional Indian study","volume":"15","author":"Shailendra Kumar","year":"2022","journal-title":"Diabetes Metab Syndr Obes"},{"key":"10.1016\/j.jdiacomp.2024.108929_bb0080","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.2147\/IJGM.S402683","article-title":"Prevalence of obesity in newly onset diabetes mellitus and its relationship with uric acid: an Indian cross-sectional study","volume":"16","author":"Shailendra Kumar","year":"2023","journal-title":"Int J Gen Med"},{"key":"10.1016\/j.jdiacomp.2024.108929_bb0085","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1093\/aje\/kwt320","article-title":"Temporal relationship between uric acid concentration and risk of diabetes in a community-based study population","volume":"179","author":"Stephen","year":"2014","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jdiacomp.2024.108929_bb0090","first-page":"81","article-title":"Elevation of serum uric acid and incidence of type 2 diabetes: a systematic review and meta-analysis","volume":"2","author":"Xu","year":"2016","journal-title":"Chronic Dis Transl Med"},{"key":"10.1016\/j.jdiacomp.2024.108929_bb0095","article-title":"High serum uric acid and increased risk of type 2 diabetes: a systemic review and meta-analysis of prospective cohort studies","volume":"8","author":"Lv","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.jdiacomp.2024.108929_bb0100","doi-asserted-by":"crossref","first-page":"4930","DOI":"10.2174\/1381612811319270016","article-title":"Uric acid and diabetes: is there a link?","volume":"19","author":"Katsiki","year":"2013","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.jdiacomp.2024.108929_bb0105","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0009-8981(82)90376-X","article-title":"Renal hypouricaemia in insulin treated diabetes mellitus","volume":"120","author":"Gotfredsen","year":"1982","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.jdiacomp.2024.108929_bb0110","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.jsps.2022.04.013","article-title":"A review on benefits of quercetin in hyperuricemia and gouty arthritis","volume":"30","author":"Nutmakul","year":"2022","journal-title":"Saudi Pharm J"},{"key":"10.1016\/j.jdiacomp.2024.108929_bb0115","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1002\/art.41779","article-title":"Assessing the causal relationships between insulin resistance and hyperuricemia and gout using bidirectional Mendelian randomization","volume":"73","author":"McCormick","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jdiacomp.2024.108929_bb0120","doi-asserted-by":"crossref","first-page":"126","DOI":"10.2337\/dc10-0918","article-title":"Serum uric acid levels predict new-onset type 2 diabetes in hospitalized patients with primary hypertension: the MAGIC study","volume":"34","author":"Viazzi","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2024.108929_bb0125","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jcjd.2014.10.013","article-title":"Uric acid as a biomarker and a therapeutic target in diabetes","volume":"39","author":"Yuliya","year":"2015","journal-title":"Can J Diabetes"},{"key":"10.1016\/j.jdiacomp.2024.108929_bb0130","first-page":"133","article-title":"A cohort study of hyperuricemia in middle-aged South Korean men","volume":"175","author":"Seungho","year":"2011","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jdiacomp.2024.108929_bb0135","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1136\/ard.2010.130013","article-title":"Impact of diabetes against the future risk of developing gout","volume":"69","author":"Rodr\u00edguez","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jdiacomp.2024.108929_bb0140","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2019-000834","article-title":"Mendelian randomization study of serum uric acid levels and diabetes risk: evidence from the Dongfeng-Tongji cohort","volume":"8","author":"Keerman","year":"2020","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/j.jdiacomp.2024.108929_bb0145","article-title":"An invert U-shaped curve: relationship between fasting plasma glucose and serum uric acid concentration in a large health check-up population in China","volume":"95","author":"Li","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jdiacomp.2024.108929_bb0150","first-page":"9","article-title":"Inverted U-shaped associations between glycemic indices and serum uric acid levels in the general Chinese population: findings from the China Cardiometabolic disease and Cancer cohort (4C) study","volume":"34","author":"Zhu","year":"2021","journal-title":"Biomed Environ Sci"},{"key":"10.1016\/j.jdiacomp.2024.108929_bb0155","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/jdi.14132","article-title":"Inverted U-shaped associations between serum uric acid and fasting - plasma glucose level in non-diabetic, pre-diabetic, and diabetic adults: a population-based study in China","volume":"15","author":"Shi","year":"2024","journal-title":"J Diabetes Investig"},{"key":"10.1016\/j.jdiacomp.2024.108929_bb0160","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1001\/jama.1991.03470210076036","article-title":"Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration","volume":"266","author":"Facchini","year":"1991","journal-title":"Jama"},{"key":"10.1016\/j.jdiacomp.2024.108929_bb0165","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/nature742","article-title":"Molecular identification of a renal urate anion exchanger that regulates blood urate levels","volume":"417","author":"Enomoto","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.jdiacomp.2024.108929_bb0170","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/709691","article-title":"The association between serum uric acid and residual \u03b2 -cell function in type 2 diabetes","volume":"2014","author":"Tang","year":"2014","journal-title":"J Diabetes Res"},{"key":"10.1016\/j.jdiacomp.2024.108929_bb0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/20503121241241934","article-title":"Elevated uric acid in gestational diabetes and its risk on pregnancy outcomes","volume":"12","author":"Ahmed","year":"2024","journal-title":"SAGE Open Med"},{"key":"10.1016\/j.jdiacomp.2024.108929_bb0180","first-page":"352","article-title":"Estimation of serum creatinine and uric acid in Bangladeshi gestational diabetic mother attending in tertiary care hospital","volume":"28","author":"Mishu","year":"2019","journal-title":"Mymensingh Med J"},{"key":"10.1016\/j.jdiacomp.2024.108929_bb0185","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/j.ophtha.2021.04.027","article-title":"Global prevalence of diabetic retinopathy and projection of burden through 2045: systematic review and meta-analysis","volume":"128","author":"Teo","year":"2021","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jdiacomp.2024.108929_bb0190","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1186\/s12886-020-01713-5","article-title":"Associations of serum uric acid and urinary albumin with the severity of diabetic retinopathy in individuals with type 2 diabetes","volume":"20","author":"Chen","year":"2020","journal-title":"BMC Ophthalmol"},{"key":"10.1016\/j.jdiacomp.2024.108929_bb0195","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1167\/iovs.62.4.23","article-title":"Higher serum uric acid levels are associated with an increased risk of vision-threatening diabetic retinopathy in type 2 diabetes patients","volume":"62","author":"Hu","year":"2021","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jdiacomp.2024.108929_bb0200","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/ceo.14344","article-title":"Insulin resistance is associated with the presence and severity of retinopathy in patients with type 2 diabetes","volume":"52","author":"Xu","year":"2024","journal-title":"Clin Exp Ophthalmol"},{"key":"10.1016\/j.jdiacomp.2024.108929_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106408","article-title":"Autophagy-nutrient sensing pathways in diabetic complications","volume":"184","author":"Parmar","year":"2022","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.jdiacomp.2024.108929_bb0210","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1161\/CIRCULATIONAHA.105.563213","article-title":"Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms","volume":"113","author":"Kim","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jdiacomp.2024.108929_bb0215","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1096\/fj.13-247148","article-title":"Uric acid induces endothelial dysfunction by vascular insulin resistance associated with the impairment of nitric oxide synthesis","volume":"28","author":"Choi","year":"2014","journal-title":"FASEB J"},{"key":"10.1016\/j.jdiacomp.2024.108929_bb0220","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0019901","article-title":"Elevated serum uric acid is associated with high circulating inflammatory cytokines in the population-based Colaus study","volume":"6","author":"Lyngdoh","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.jdiacomp.2024.108929_bb0225","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0202156","article-title":"Intravitreal pro-inflammatory cytokines in non-obese diabetic mice: modelling signs of diabetic retinopathy","volume":"13","author":"Mugisho","year":"2018","journal-title":"PloS One"},{"key":"10.1016\/j.jdiacomp.2024.108929_bb0230","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.564077","article-title":"Microglia and inflammatory responses in diabetic retinopathy","volume":"11","author":"Kinuthia","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jdiacomp.2024.108929_bb0235","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.bbrc.2018.06.097","article-title":"The role of uric acid in the pathogenesis of diabetic retinopathy based on notch pathway","volume":"503","author":"Zhu","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jdiacomp.2024.108929_bb0240","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1056\/NEJMc1602469","article-title":"Trends in chronic kidney disease in China","volume":"375","author":"Zhang","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jdiacomp.2024.108929_bb0245","doi-asserted-by":"crossref","first-page":"S151","DOI":"10.2337\/dc21-S011","article-title":"11. Microvascular complications and foot care: standards of medical care in diabetes-2021","volume":"44","author":"AD","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2024.108929_bb0250","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.2215\/CJN.11491116","article-title":"Diabetic kidney disease: challenges, progress, and possibilities","volume":"12","author":"Alicic","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jdiacomp.2024.108929_bb0255","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","article-title":"Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"395","author":"GBDCKD C","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jdiacomp.2024.108929_bb0260","article-title":"Uric acid is independently associated with diabetic kidney disease: a cross-sectional study in a Chinese population","volume":"10","author":"Yan","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.jdiacomp.2024.108929_bb0265","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.pcd.2022.03.003","article-title":"Serum uric acid levels and diabetic kidney disease in patients with type 2 diabetes mellitus: a dose-response meta-analysis","volume":"16","author":"Ji","year":"2022","journal-title":"Prim Care Diabetes"},{"key":"10.1016\/j.jdiacomp.2024.108929_bb0270","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s00592-015-0825-x","article-title":"Association of serum uric acid levels with the risk of development or progression of albuminuria among Japanese patients with type 2 diabetes: a prospective cohort study [Diabetes Distress and Care Registry at Tenri (DDCRT 10)]","volume":"53","author":"Hayashino","year":"2016","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.jdiacomp.2024.108929_bb0275","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1186\/s12882-023-03302-2","article-title":"The correlation between serum uric acid and diabetic kidney disease in type 1 diabetes patients in Anhui, China","volume":"24","author":"Jiang","year":"2023","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.jdiacomp.2024.108929_bb0280","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4093\/dmj.2021.0280","article-title":"Insulin resistance: from mechanisms to therapeutic strategies","volume":"46","author":"Lee","year":"2022","journal-title":"Diabetes Metab J"},{"key":"10.1016\/j.jdiacomp.2024.108929_bb0285","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S2213-8587(18)30051-2","article-title":"Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables","volume":"6","author":"Ahlqvist","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jdiacomp.2024.108929_bb0290","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s12916-021-01936-3","article-title":"Insulin resistance, diabetic kidney disease, and all-cause mortality in individuals with type 2 diabetes: a prospective cohort study","volume":"19","author":"Penno","year":"2021","journal-title":"BMC Med"},{"key":"10.1016\/j.jdiacomp.2024.108929_bb0295","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1080\/0886022X.2022.2036620","article-title":"Research progress on related mechanisms of uric acid activating NLRP3 inflammasome in chronic kidney disease","volume":"44","author":"Wang","year":"2022","journal-title":"Ren Fail"},{"key":"10.1016\/j.jdiacomp.2024.108929_bb0300","article-title":"Inflammatory cytokines in diabetic kidney disease: pathophysiologic and therapeutic implications","volume":"7","author":"Donate-Correa","year":"2020","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jdiacomp.2024.108929_bb0305","doi-asserted-by":"crossref","first-page":"F471","DOI":"10.1152\/ajprenal.00560.2012","article-title":"Uric acid-induced phenotypic transition of renal tubular cells as a novel mechanism of chronic kidney disease","volume":"304","author":"Ryu","year":"2013","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.jdiacomp.2024.108929_bb0310","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.molimm.2015.03.250","article-title":"Soluble monosodium urate, but not its crystal, induces toll like receptor 4-dependent immune activation in renal mesangial cells","volume":"66","author":"Xiao","year":"2015","journal-title":"Mol Immunol"},{"key":"10.1016\/j.jdiacomp.2024.108929_bb0315","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1136\/annrheumdis-2014-206564","article-title":"Soluble uric acid primes TLR-induced proinflammatory cytokine production by human primary cells via inhibition of IL-1Ra","volume":"75","author":"Cri\u0219an","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jdiacomp.2024.108929_bb0320","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1111\/jcmm.13060","article-title":"Signalling pathways involved in hypoxia-induced renal fibrosis","volume":"21","author":"Liu","year":"2017","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.jdiacomp.2024.108929_bb0325","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1111\/dme.13051","article-title":"Plasma uric acid effects on glomerular haemodynamic profile of patients with uncomplicated type 1 diabetes mellitus","volume":"33","author":"Lytvyn","year":"2016","journal-title":"Diabet Med"},{"key":"10.1016\/j.jdiacomp.2024.108929_bb0330","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.2337\/db17-0168","article-title":"Renal and vascular effects of uric acid lowering in normouricemic patients with uncomplicated type 1 diabetes","volume":"66","author":"Lytvyn","year":"2017","journal-title":"Diabetes"},{"key":"10.1016\/j.jdiacomp.2024.108929_bb0335","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1111\/j.1464-5491.2011.03349.x","article-title":"Uric acid levels are associated with microvascular endothelial dysfunction in patients with type 1 diabetes","volume":"28","author":"Matheus","year":"2011","journal-title":"Diabet Med"},{"key":"10.1016\/j.jdiacomp.2024.108929_bb0340","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s12882-019-1275-4","article-title":"Hyperuricemia and its related histopathological features on renal biopsy","volume":"20","author":"Fan","year":"2019","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.jdiacomp.2024.108929_bb0345","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/S1474-4422(22)00188-0","article-title":"Towards prevention of diabetic peripheral neuropathy: clinical presentation, pathogenesis, and new treatments","volume":"21","author":"Elafros","year":"2022","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jdiacomp.2024.108929_bb0350","series-title":"Diagnosis and Management of Diabetic Foot Complications","author":"Boulton","year":"2018"},{"key":"10.1016\/j.jdiacomp.2024.108929_bb0355","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/mus.27086","article-title":"Metabolic syndrome and peripheral neuropathy","volume":"63","author":"Kazamel","year":"2021","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jdiacomp.2024.108929_bb0360","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.2337\/db19-1046","article-title":"Risk factors for diabetic peripheral neuropathy and cardiovascular autonomic neuropathy in the diabetes control and complications trial\/epidemiology of diabetes interventions and complications (DCCT\/EDIC) study","volume":"69","author":"Braffett","year":"2020","journal-title":"Diabetes"},{"key":"10.1016\/j.jdiacomp.2024.108929_bb0365","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jns.2018.04.025","article-title":"Correlation between serum uric acid and diabetic peripheral neuropathy - association rather than causation","volume":"390","author":"Bell","year":"2018","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jdiacomp.2024.108929_bb0370","doi-asserted-by":"crossref","first-page":"189","DOI":"10.4082\/kjfm.18.0205","article-title":"The association between serum uric acid and peripheral neuropathy in patients with type 2 diabetes mellitus: a Multicenter Nationwide CrossSectional study","volume":"41","author":"Kaewput","year":"2020","journal-title":"Korean J Fam Med"},{"key":"10.1016\/j.jdiacomp.2024.108929_bb0375","doi-asserted-by":"crossref","first-page":"1277984","DOI":"10.3389\/fendo.2023.1277984","article-title":"Serum uric acid and risk of diabetic neuropathy: a genetic correlation and mendelian randomization study","volume":"14","author":"Zhang","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.jdiacomp.2024.108929_bb0380","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00592-010-0176-6","article-title":"Insulin resistance is independently associated with peripheral and autonomic neuropathy in Korean type 2 diabetic patients","volume":"49","author":"Lee","year":"2012","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.jdiacomp.2024.108929_bb0385","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.it.2003.10.013","article-title":"Inflammation: the link between insulin resistance, obesity and diabetes","volume":"25","author":"Dandona","year":"2004","journal-title":"Trends Immunol"},{"key":"10.1016\/j.jdiacomp.2024.108929_bb0390","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s11154-012-9229-1","article-title":"Role of insulin resistance in endothelial dysfunction","volume":"14","author":"Muniyappa","year":"2013","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1016\/j.jdiacomp.2024.108929_bb0395","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3389\/fendo.2012.00170","article-title":"Inflammation in the pathogenesis of microvascular complications in diabetes","volume":"3","author":"Nguyen","year":"2012","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.jdiacomp.2024.108929_bb0400","doi-asserted-by":"crossref","first-page":"112","DOI":"10.7570\/jomes.2019.28.2.112","article-title":"Association between body fat and diabetic peripheral neuropathy in middle-aged adults with type 2 diabetes mellitus: a preliminary report","volume":"28","author":"Oh","year":"2019","journal-title":"J Obes Metab Syndr"},{"key":"10.1016\/j.jdiacomp.2024.108929_bb0405","doi-asserted-by":"crossref","first-page":"6928","DOI":"10.3892\/mmr.2017.7405","article-title":"Uric acid induces the expression of TNF-\u03b1 via the ROS-MAPK-NF-\u03baB signaling pathway in rat vascular smooth muscle cells","volume":"16","author":"Tang","year":"2017","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.jdiacomp.2024.108929_bb0410","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1080\/10799893.2016.1203941","article-title":"Uric acid stimulates proliferative pathways in vascular smooth muscle cells through the activation of p38 MAPK, p44\/42 MAPK and PDGFR\u03b2","volume":"37","author":"K\u0131r\u00e7a","year":"2017","journal-title":"J Recept Signal Transduct Res"},{"key":"10.1016\/j.jdiacomp.2024.108929_bb0415","doi-asserted-by":"crossref","first-page":"282","DOI":"10.2174\/0929866527666200921165312","article-title":"Protective potential of uric acid, folic acid, glutathione and ascorbic acid against the formation of toxic met-myoglobin","volume":"28","author":"Al Abdulmonem","year":"2021","journal-title":"Protein Pept Lett"},{"key":"10.1016\/j.jdiacomp.2024.108929_bb0420","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2017-211423","article-title":"SUA levels should not be maintained <3 mg\/dL for several years. Response to \u201cEULAR gout treatment guidelines by Richette et al: uric acid and neurocognition by Singh et al\u201d","volume":"77","author":"Richette","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jdiacomp.2024.108929_bb0425","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s13300-010-0006-4","article-title":"Quantitative PCR tissue expression profiling of the human SGLT2 gene and related family members","volume":"1","author":"Chen","year":"2010","journal-title":"Diabetes Ther"},{"key":"10.1016\/j.jdiacomp.2024.108929_bb0430","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1177\/1479164114561992","article-title":"Probing SGLT2 as a therapeutic target for diabetes: basic physiology and consequences","volume":"12","author":"Gallo","year":"2015","journal-title":"Diab Vasc Dis Res"},{"key":"10.1016\/j.jdiacomp.2024.108929_bb0435","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.jacc.2019.11.031","article-title":"Mechanisms of cardiorenal effects of sodium-glucose cotransporter 2 inhibitors: JACC state-of-the-art review","volume":"75","author":"Zelniker","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jdiacomp.2024.108929_bb0440","doi-asserted-by":"crossref","first-page":"663","DOI":"10.2215\/CJN.11480821","article-title":"SGLT2 inhibition and uric acid excretion in patients with type 2 diabetes and normal kidney function","volume":"17","author":"Suijk","year":"2022","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jdiacomp.2024.108929_bb0445","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/dom.13101","article-title":"Effects of sodium-glucose co-transporter 2 (SGLT2) inhibitors on serum uric acid level: a meta-analysis of randomized controlled trials","volume":"20","author":"Zhao","year":"2018","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.jdiacomp.2024.108929_bb0450","doi-asserted-by":"crossref","first-page":"F173","DOI":"10.1152\/ajprenal.00462.2018","article-title":"SGLT2 inhibition and renal urate excretion: role of luminal glucose, GLUT9, and URAT1","volume":"316","author":"Novikov","year":"2019","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.jdiacomp.2024.108929_bb0455","doi-asserted-by":"crossref","first-page":"437","DOI":"10.2147\/DMSO.S399343","article-title":"The mechanism of sodium-glucose cotransporter-2 inhibitors in reducing uric acid in type 2 diabetes mellitus","volume":"16","author":"Dong","year":"2023","journal-title":"Diabetes Metab Syndr Obes"},{"key":"10.1016\/j.jdiacomp.2024.108929_bb0460","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.cardfail.2020.08.015","article-title":"Uric acid is a biomarker of oxidative stress in the failing heart: lessons learned from trials with allopurinol and SGLT2 inhibitors","volume":"26","author":"Packer","year":"2020","journal-title":"J Card Fail"},{"key":"10.1016\/j.jdiacomp.2024.108929_bb0465","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s12020-016-0896-7","article-title":"SIRT1 prevents hyperuricemia via the PGC-1\u03b1\/PPAR\u03b3-ABCG2 pathway","volume":"53","author":"Wang","year":"2016","journal-title":"Endocrine"},{"key":"10.1016\/j.jdiacomp.2024.108929_bb0470","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1038\/s41467-020-15983-6","article-title":"SGLT2 inhibition modulates NLRP3 inflammasome activity via ketones and insulin in diabetes with cardiovascular disease","volume":"11","author":"Kim","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.jdiacomp.2024.108929_bb0475","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s11906-022-01170-z","article-title":"Targeting features of the metabolic syndrome through sympatholytic effects of SGLT2 inhibition","volume":"24","author":"Herat","year":"2022","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.jdiacomp.2024.108929_bb0480","doi-asserted-by":"crossref","first-page":"50","DOI":"10.21037\/cdt-20-830","article-title":"4","volume":"11","author":"Wang","year":"2021","journal-title":"Cardiovasc Diagn Ther"},{"key":"10.1016\/j.jdiacomp.2024.108929_bb0485","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7150\/ijbs.33007","article-title":"Empagliflozin attenuates hyperuricemia by upregulation of ABCG2 via AMPK\/AKT\/CREB signaling pathway in type 2 diabetic mice","volume":"16","author":"Lu","year":"2020","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.jdiacomp.2024.108929_bb0490","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1124\/jpet.119.259341","article-title":"Pharmacological evaluation of dotinurad, a selective urate reabsorption inhibitor","volume":"371","author":"Taniguchi","year":"2019","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jdiacomp.2024.108929_bb0495","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.133817","article-title":"Gut-derived uremic toxin handling in vivo requires OAT-mediated tubular secretion in chronic kidney disease","volume":"5","author":"Bush","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.jdiacomp.2024.108929_bb0500","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.005022","article-title":"Indoxyl sulfate: a novel cardiovascular risk factor in chronic kidney disease","volume":"6","author":"Hung","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jdiacomp.2024.108929_bb0505","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s10157-019-01818-2","article-title":"Clinical efficacy and safety of dotinurad, a novel selective urate reabsorption inhibitor, in Japanese hyperuricemic patients with or without gout: randomized, multicenter, double-blind, placebo-controlled, parallel-group, confirmatory phase 2 study","volume":"24","author":"Hosoya","year":"2020","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.jdiacomp.2024.108929_bb0510","doi-asserted-by":"crossref","first-page":"1042061","DOI":"10.3389\/fendo.2022.1042061","article-title":"Efficacy and safety of switching from febuxostat to dotinurad, a novel selective urate reabsorption inhibitor, in hyperuricemic patients with type 2 diabetic kidney disease: protocol for a single-arm, open-label, prospective, exploratory study","volume":"13","author":"Osonoi","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.jdiacomp.2024.108929_bb0515","doi-asserted-by":"crossref","first-page":"567","DOI":"10.3390\/biomedicines11020567","article-title":"Urate transporter 1 can be a therapeutic target molecule for chronic kidney disease and diabetic kidney disease: a retrospective longitudinal study","volume":"11","author":"Yanai","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.jdiacomp.2024.108929_bb0520","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1186\/s40001-023-01208-1","article-title":"Clinical effects of a selective urate reabsorption inhibitor dotinurad in patients with hyperuricemia and treated hypertension: a multicenter, prospective, exploratory study (DIANA)","volume":"28","author":"Tanaka","year":"2023","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.jdiacomp.2024.108929_bb0525","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1080\/14397595.2018.1538003","article-title":"Safety and efficacy of verinurad, a selective URAT1 inhibitor, for the treatment of patients with gout and\/or asymptomatic hyperuricemia in the United States and Japan: findings from two phase II trials","volume":"29","author":"Fitz-Patrick","year":"2019","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.jdiacomp.2024.108929_bb0530","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1053\/j.ajkd.2020.09.009","article-title":"Effect of intensive urate lowering with combined Verinurad and Febuxostat on albuminuria in patients with type 2 diabetes: a randomized trial","volume":"77","author":"Stack","year":"2021","journal-title":"Am J Kidney Dis"}],"container-title":["Journal of Diabetes and its Complications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872724002551?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872724002551?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T11:53:47Z","timestamp":1739015627000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056872724002551"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":106,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S1056872724002551"],"URL":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2024.108929","relation":{},"ISSN":["1056-8727"],"issn-type":[{"value":"1056-8727","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Uric acid in diabetic microvascular complications: Mechanisms and therapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Diabetes and its Complications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2024.108929","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors.","name":"copyright","label":"Copyright"}],"article-number":"108929"}}